DK158281C - Fremgangsmaade til fremstilling af et faktor viii (ahf)-holdigt praeparat - Google Patents

Fremgangsmaade til fremstilling af et faktor viii (ahf)-holdigt praeparat

Info

Publication number
DK158281C
DK158281C DK241584A DK241584A DK158281C DK 158281 C DK158281 C DK 158281C DK 241584 A DK241584 A DK 241584A DK 241584 A DK241584 A DK 241584A DK 158281 C DK158281 C DK 158281C
Authority
DK
Denmark
Prior art keywords
factor viii
ahf
units
preparing
procedure
Prior art date
Application number
DK241584A
Other languages
Danish (da)
English (en)
Other versions
DK241584D0 (da
DK241584A (da
DK158281B (da
Inventor
Yendra Linnau
Otto Schwarz
Original Assignee
Immuno Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immuno Ag filed Critical Immuno Ag
Publication of DK241584D0 publication Critical patent/DK241584D0/da
Publication of DK241584A publication Critical patent/DK241584A/da
Publication of DK158281B publication Critical patent/DK158281B/da
Application granted granted Critical
Publication of DK158281C publication Critical patent/DK158281C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y10S530/83—Plasma; serum

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
DK241584A 1983-05-20 1984-05-16 Fremgangsmaade til fremstilling af et faktor viii (ahf)-holdigt praeparat DK158281C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AT185883 1983-05-20
AT0185883A AT379510B (de) 1983-05-20 1983-05-20 Verfahren zur herstellung einer faktor viii (ahf) -haeltigen praeparation

Publications (4)

Publication Number Publication Date
DK241584D0 DK241584D0 (da) 1984-05-16
DK241584A DK241584A (da) 1984-11-21
DK158281B DK158281B (da) 1990-04-30
DK158281C true DK158281C (da) 1990-10-01

Family

ID=3522525

Family Applications (1)

Application Number Title Priority Date Filing Date
DK241584A DK158281C (da) 1983-05-20 1984-05-16 Fremgangsmaade til fremstilling af et faktor viii (ahf)-holdigt praeparat

Country Status (8)

Country Link
US (1) US4522751A (es)
EP (1) EP0127603B1 (es)
JP (1) JPS59222420A (es)
AT (2) AT379510B (es)
CA (1) CA1225331A (es)
DE (1) DE3475871D1 (es)
DK (1) DK158281C (es)
ES (1) ES532640A0 (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8403473D0 (en) * 1984-02-09 1984-03-14 Special Trustees For St Thomas Purification of factor viii
US4965199A (en) * 1984-04-20 1990-10-23 Genentech, Inc. Preparation of functional human factor VIII in mammalian cells using methotrexate based selection
GB8505882D0 (en) * 1985-03-07 1985-04-11 Central Blood Lab Authority Purification of blood coagulation factor viii
DE3512910A1 (de) * 1985-04-11 1986-10-16 Behringwerke Ag, 3550 Marburg Verfahren zur reinigung von plasminogenaktivatoren
DE3625090A1 (de) * 1986-07-24 1988-01-28 Behringwerke Ag Mittel zur therapie faktor viii-resistenter haemophilie a und verfahren zu seiner herstellung
AT391808B (de) * 1986-11-03 1990-12-10 Immuno Ag Verfahren zur herstellung einer faktor viii (ahf)-haeltigen fraktion
AT391809B (de) * 1988-01-12 1990-12-10 Immuno Ag Verfahren zur inaktivierung von vermehrungsfaehigen filtrierbaren krankheitserregern in blutplasmaprodukten
US5110907A (en) * 1989-08-01 1992-05-05 Alpha Therapeutic Corporation Factor viii complex purification using heparin affinity chromatography
FR2659557A1 (fr) * 1990-03-15 1991-09-20 Fondation Nale Transfusion San Procede de preparation d'une solution concentree de facteur viii.
FR2665364A2 (fr) * 1990-03-15 1992-02-07 Fondation Nale Transfusion San Procede de preparation d'une solution concentree de facteur viii.
US5278289A (en) * 1991-11-12 1994-01-11 Johnson Alan J Antihemophilic factor stabilization
JP5149470B2 (ja) 1999-02-22 2013-02-20 バクスター・インターナショナル・インコーポレイテッド 新規のアルブミンを含有していない第ｖｉｉｉ因子処方物
ES2229931B1 (es) * 2003-10-03 2006-01-16 Grifols, S.A. Composicion liquida bilogicamente estable de fviii, de fvw o del complejo fviii/fvw humanos.
DK2126106T3 (en) 2007-02-23 2017-12-04 Sk Chemicals Co Ltd Process for the preparation and purification of Factor VIII and its derivatives
CA2742328C (en) 2008-11-07 2019-02-26 Baxter International Inc. Factor viii formulations
JP2014138614A (ja) * 2014-04-09 2014-07-31 Sk Chemicals Co Ltd 第ｖｉｉｉ因子とその誘導体の製造及び精製方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE392038B (sv) * 1971-09-08 1977-03-14 Kabi Ab Forfarande for isolering av antitrombin ur blod eller blodprodukter
US4022758A (en) * 1973-06-19 1977-05-10 Ab Kabi Isolation of coagulation factors I and VIII from biological material
US3973002A (en) * 1974-04-12 1976-08-03 E. R. Squibb & Sons, Inc. Antihemophilic factor
US4069216A (en) * 1975-06-16 1978-01-17 Edward Shanbrom, Inc. Simplified methods for preparation of very high purity Factor VIII concentrate
CA1054052A (en) * 1976-08-14 1979-05-08 Edward Shanbrom Simplified method for preparation of high yield, high purity factor viii concentrate
US4104266A (en) * 1977-04-14 1978-08-01 American National Red Cross Method for preparation of antihemophilic factor
CA1074698A (en) * 1977-12-19 1980-04-01 Gail A. Rock Method of collecting anti-hemophilic factor viii from blood and blood plasma
US4170639A (en) * 1978-07-10 1979-10-09 Warner-Lambert Company Antihemophilic factor concentrate and its production
AT359646B (de) * 1979-04-19 1980-11-25 Immuno Ag Verfahren zur herstellung von nebenwirkungs- freien plasmafraktionen
US4210580A (en) * 1979-06-19 1980-07-01 David Amrani Process for separation and isolation of AHF and fibronectin from blood plasma
US4289691A (en) * 1980-01-18 1981-09-15 The Canadian Red Cross Society Method of obtaining intermediate purity factor VIII
AT368883B (de) * 1980-07-22 1982-11-25 Immuno Ag Verfahren zur herstellung einer neuen blutgerinnungsfoerdernden praeparation auf basis von humanproteinen
AT369263B (de) * 1980-08-27 1982-12-27 Immuno Ag Verfahren zur herstellung eines faktor viii(ahf) -hochkonzentrates
US4361509A (en) * 1981-12-14 1982-11-30 Scripps Clinic And Research Foundation Ultrapurification of factor VIII using monoclonal antibodies

Also Published As

Publication number Publication date
DK241584D0 (da) 1984-05-16
ES8505822A1 (es) 1985-06-16
CA1225331A (en) 1987-08-11
JPH0553777B2 (es) 1993-08-10
DK241584A (da) 1984-11-21
EP0127603A2 (de) 1984-12-05
EP0127603A3 (en) 1986-09-03
AT379510B (de) 1986-01-27
DE3475871D1 (en) 1989-02-09
ES532640A0 (es) 1985-06-16
EP0127603B1 (de) 1989-01-04
JPS59222420A (ja) 1984-12-14
ATA185883A (de) 1985-06-15
ATE39618T1 (de) 1989-01-15
DK158281B (da) 1990-04-30
US4522751A (en) 1985-06-11

Similar Documents

Publication Publication Date Title
DK158281C (da) Fremgangsmaade til fremstilling af et faktor viii (ahf)-holdigt praeparat
ES8501979A1 (es) Procedimiento para preparar un concentrado de factor antihemofilico
NO177188C (no) Fremgangsmåte for separering av humane eller animalske plasmaproteiner
DK450785D0 (da) Fremgangsmaade til fremstilling af et koncentrat af antihaemofilisk faktor med hoej renhed
SE8104482L (sv) Forfarande for framstellning av ett faktor viii (ahf)-hogkoncentrat
DK573587D0 (da) Fremgangsmaade til fremstilling af en faktor viii (ahf)-holdig fraktion
FI844557L (fi) Koncentrat av antihemofilfaktorn viii och foerfarande foer framstaellning av detsamma.
DK241684A (da) Fremgangsmaade til fremstilling af et antithrombin iii-heparin- eller antithrombin iii-heparinoidkoncentrat
JPS57193494A (en) Method of purifying or concentrating biologically active protein and drug therefor
ATE44750T1 (de) Verfahren zur herstellung eines antihaemophiliefaktor-konzentrats.
Sahu et al. Structure of carbohydrate chains of a high-molecular-weight pulmonary glycoprotein
KR920005994A (ko) 전체혈장으로 혈액응고 viii 인자-반 빌레브란트 인자 복합 농축물을 제조하는 방법

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment